Alnylam Pharmaceuticals Inc (ALNY) — institutional ownership

839 funds reported holding Alnylam Pharmaceuticals Inc in their latest 13F filings, worth $48.5B in total (CUSIP 02043Q107).

Largest holders

1. VANGUARD GROUP INC — $5.39B
2. FMR LLC — $4.52B
3. Capital World Investors — $3.35B
4. BlackRock, Inc. (BLK) — $3.28B
5. Capital Research Global Investors — $2.94B
6. Banque Cantonale Vaudoise — $2.20B
7. VANGUARD PORTFOLIO MANAGEMENT LLC — $1.97B
8. VANGUARD CAPITAL MANAGEMENT LLC — $1.82B
9. T. Rowe Price Investment Management, Inc. — $1.70B
10. Invesco Ltd. (IVZ) — $1.13B

Famous investors holding it

• Two Sigma portfolio (Two Sigma Investments)
• D. E. Shaw portfolio (D. E. Shaw & Co.)
• Izzy Englander portfolio (Millennium Management)
• Ken Griffin portfolio (Citadel Advisors)
• Ray Dalio portfolio (Bridgewater Associates)

Insider buying and selling at Alnylam Pharmaceuticals Inc

Who owns the most ALNY stock?

The largest institutional holders in the latest 13F filings are VANGUARD GROUP INC ($5.39B), FMR LLC ($4.52B), Capital World Investors ($3.35B).

How many funds own ALNY?

839 funds reported holding it, worth $48.5B in total.